NDI P7 Position Sensor, Stereotaxic Instrument

FDA Device Recall #Z-2048-2017 - Class II, June 9, 2009

Recall Summary

Recall Number Z-2048-2017
Classification Class II - Moderate risk
Date Initiated June 9, 2009
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Orthosoft, Inc. dba Zimmer CAS
Location Montreal, N/A
Product Type Devices
Quantity 34

Product Description

NDI P7 Position Sensor, Stereotaxic Instrument

Reason for Recall

Zimmer CAS voluntarily conducted a retrospective recall on specific P7 Position Sensors (Cameras), installed on Sesamoid and Sesamoid Plasty CAS workstations due to a series of these components determined to be affected with a manufacturing issue whereby they may potentially stop functioning during usage.

Distribution Pattern

Worldwide Distribution - US Distribution to the states of : KS, MS, WI, NJ, KS, IN, LA, FL and WA., and to the countries of : Canada, Australia, Singapore, Netherlands, UK, Austria, Germany, Switzerland and Czech Republic.

Lot / Code Information

Part Number: NDI P7 Position Sensor Product Number 201.053 (a component of part number 521.035, Sesamoid Plasty Camera Arm Kit) Lot/Serial Number: 38 units affected: P7-00321, P7-00339, P7-00360, P7-00361, P7-00362, P7-00363, P7-00364, P7-00365, P7-00366, P7-00368, P7-00369, P7-00370, P7-00371, P7-00372, P7-00373, P7-00375, P7-00387, P7-00412, P7-00414, P7-00415, P7-00416, P7-00417, P7-00418, P7-00419, P7-00420, P7-00421, P7-00422, P7-00423, P7-00431, P7-00451, P7-00452, P7-00453, P7-00562, P7-00563, P7-00565, P7-00568, P7-00569, P7-00590 (The lot number and the serial number are the same)

Other Recalls from Orthosoft, Inc. dba Zimmer CAS

Recall # Classification Product Date
Z-0721-2022 Class II NavitrackER Kit A: Knee, Model Number 20-8000-0... Jan 7, 2022
Z-1868-2017 Class II SmartTools Knee System Orthopedic Stereotaxic ... Feb 20, 2017
Z-1881-2017 Class II Navitrack System - OS Knee Universal, Orthopedi... Oct 6, 2011
Z-2076-2017 Class II Navitrack System - OS Knee Universal, Stereotax... Oct 28, 2008
Z-2075-2017 Class III Navitrack¿ System - OS Knee Universal, Orthoped... Jun 20, 2008

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.